Impact Factor 4.716 | CiteScore 4.71
More on impact ›

Erratum ARTICLE

Front. Immunol., 02 December 2019 | https://doi.org/10.3389/fimmu.2019.02905

Erratum: Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action

by Buckley, P. R., Alden, K., Coccia, M., Chalon, A., Collignon, C., Temmerman, S. T., et al. (2019). Front. Immunol. 10:2150. doi: 10.3389/fimmu.2019.02150

Due to a production error, the author “Mark C. Coles” was not added in the Conflict of Interest Statement. The correct statement should read:

“CA, RM, AD, MC, and ST report ownership of GSK shares and/or restricted GSK shares.”

Furthermore, there is a typo in the city of Affiliation 4. Instead of “Faculty of Technology, University of Sunderland, Sunderlandm, United Kingdom” it should be “Faculty of Technology, University of Sunderland, Sunderland, United Kingdom.”

Lastly, the caption provided in Figure S1 is incorrect. The correct caption should read:

Figure S1. The CellDesigner Model captures the following key compartments: the muscle injection site (A), the lymphatic vessels (B), the draining lymph node (dLN) [including paracortex (C), B cell follicles (D), germinal center (E)], the blood (F), and the bone marrow (G). This model captures high-level mechanisms that are hypothesized to give rise to the phenomena observed by experimentation in mice. This begins with the intramuscular injection (34) of the vaccine at time zero (A) and captures the events leading to the secretion and circulation of antibodies (E,F), and lymph node egression of effector memory T cells (9).”

The publisher apologizes for these mistakes. The original article has been updated.

Keywords: vaccines, adjuvants, mathematical modeling, computational biology, systems biology, mechanistic modeling, AS01

Citation: Frontiers Production Office (2019) Erratum: Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action. Front. Immunol. 10:2905. doi: 10.3389/fimmu.2019.02905

Received: 25 November 2019; Accepted: 26 November 2019;
Published: 02 December 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org